Wright Medical Group

Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands.

Wright Medical (WMGI) delivered earnings and revenue surprises of 100.00% and -1.62%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Wright Medical Group (WMGI) Q2 Earnings Top Estimates

Wright Medical (WMGI) continues to benefit from strong international sales, new product launches and solid prospects in the global Orthopedic space.

Here's Why You Should Invest in Wright Medical Stock Now

Wright Medical (WMGI) reported earnings 30 days ago. What's next for the stock?

Wright Medical (WMGI) Up 1.3% Since Last Earnings Report: Can It Continue?

Chipotle

Campbell Soup

General Motors

Levi Strauss

Toyota Motor

U.S. companies have begun to respond to President Donald Trump's proposed tariffs on Mexican imports with mixed comments on the effects they would have on them and their customers.

Factbox: Effect of potential Mexico tariffs on U.S. companies

Wright Medical (WMGI) Q1 results benefit from higher revenues, solid show by Lower as well as Upper Extremities segments and gross margin expansion. However, rising costs remain a woe.

Wright Medical (WMGI) Q1 Earnings & Revenues Top Estimates

Wright Medical Group N.V. (WMGI) CEO Bob Palmisano on Q1 2019 Results - Earnings Call Transcript

Wright Medical delivers a strong, no-drama quarter with acceleration across all the major businesses.

Wright Medical - No Fuss, No Drama, Just A Good Quarter

Wright Medical (WMGI) delivered earnings and revenue surprises of 66.67% and 1.57%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Wright Medical Group (WMGI) Beats Q1 Earnings and Revenue Estimates

Wright Medical (WMGI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Wright Medical Group (WMGI) Reports Next Week: Wall Street Expects Earnings Growth

Wright Medical (WMGI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why Is Wright Medical (WMGI) Up 1.9% Since Last Earnings Report?

Carbonite

Columbia Sportswear Company

Palo Alto Networks

Tactile Systems

These top-ranked stocks are likely to beat on the bottom line in their next release.

News for Wright Medical Group Stock (WMGI)